Antineoplastic agents
Investigations at Genentech Inc. in South San Francisco, California, have led to the development of a groundbreaking computational procedure, REFINED, which significantly enhances predictive performance in anticancer drug sensitivity prediction tasks. This innovative methodology maps high-dimensional feature vectors into compact 2D images, enabling the application of convolutional neural networks (CNNs)
Antineoplastic agents
Investigations at Genentech Inc. in South San Francisco, California, have led to the development of a groundbreaking computational procedure, REFINED, which significantly enhances predictive performance in anticancer drug sensitivity prediction tasks. This innovative methodology maps high-dimensional feature vectors into compact 2D images, enabling the application of convolutional neural networks (CNNs)
Antineoplastic agents
Investigations at Genentech Inc. in South San Francisco, California, have led to the development of a groundbreaking computational procedure, REFINED, which significantly enhances predictive performance in anticancer drug sensitivity prediction tasks. This innovative methodology maps high-dimensional feature vectors into compact 2D images, enabling the application of convolutional neural networks (CNNs)
Antineoplastic agents
A new review published in The Kaohsiung Journal of Medical Sciences highlights the potential of nanotechnology in transforming skin cancer treatment. Researchers from Chang Gung University of Science and Technology, led by Ching-Yun Hsu, have summarized the recent advances in nanocarrier-based approaches for skin cancer therapy. The study emphasizes the
Antiacne agents
Researchers at the Beijing University of Chinese Medicine have conducted a comprehensive analysis of adverse events associated with the use of isotretinoin, a widely prescribed oral retinoid medication for acne. The study, published in the Frontiers in Medicine journal, scrutinized over 46,000 reports of adverse events linked to isotretinoin
Antineoplastic agents
Research conducted by a team of experts from the Indiana University School of Medicine has led to the development of an artificial intelligence-powered diagnostic tool for distinguishing between renal oncocytic tumors and a subset of tumors with overlapping characteristics. The study, published in the Archives of Pathology & Laboratory Medicine,
Antineoplastic agents
A new study conducted by researchers at Dokuz Eylul University in Izmir, Turkey, has uncovered a significant association between serum uric acid levels and survival outcomes in patients with metastatic renal cell carcinoma treated with targeted therapies. The research, published in the journal BMC Cancer, analyzed the prognostic importance of
Androgens
People living with metastatic prostate cancer in England will gain access to a new treatment combination from Friday, 24 October, following a recommendation by NICE. The treatment, darolutamide, made by Bayer, has been recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen
Antineoplastic agents
People living with metastatic prostate cancer in England will gain access to a new treatment combination from today, following a recommendation by NICE. Darolutamide, also known as Nubeqa, is a medication that blocks the hormones fuelling cancer growth by starving prostate cancer cells of the testosterone they need to multiply
Antineoplastic agents
A research team at the Massachusetts Institute of Technology (MIT) has made significant progress in developing tablets that can deliver cancer drugs more steadily into the bloodstream, potentially improving effectiveness and reducing side effects. The team, led by Zach Winn, has developed a 3D-printed fiber-based tablet that turns into a
Cancer
Researchers have discovered that tumor necrosis factor (TNF) plays a critical role in the development of colorectal cancer (CRC) through cellular reprogramming in intestinal epithelial cells. According to a new report published in Cell Communication and Signaling, prolonged TNF exposure can trigger CRC progression by inducing the expression of doublecortin-like
Cancer
Researchers at Guangzhou University of Chinese Medicine have made a significant discovery in the field of cancer immunotherapy. A new customized immunomodulator, developed by the team, has been shown to comprehensively reinforce the anti-tumor immunological cascade. This breakthrough has the potential to enhance the efficacy of immunotherapy for cold tumors,
